TCL Archive Moloney Convinces Most NCAB Members Of Virus Program Value, Shubik Only Dissenter October 15, 1976
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009